Penumbra, fresh off its entrance into the peripheral vascular market, last week registered for an initial public offering worth $115 million.
Alameda, Calif.-based Penumbra also makes devices for treating neurovascular conditions including hemorrhagic and ischemic stroke. The company reported sales of $125.5 million last year, up 41.3% over 2013. Founded in 2004, Penumbra said it employs about 1,000 workers.
Help employers find you! Check out all the jobs and post your resume.
